Antidiabetic combinations
https://themeditary.com/dosage-information/steglujan-dosage-4086.html

Steglujan Dosage

Drug Detail:Steglujan (Ertugliflozin and sitagliptin)

Generic Name: ERTUGLIFLOZIN PIDOLATE 5mg, SITAGLIPTIN PHOSPHATE 100mg

Dosage Form: tablet, film coated

Drug Class: Antidiabetic combinations

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Prior to Initiation of STEGLUJAN

  • Assess renal function prior to initiation of STEGLUJAN and as clinically indicated [see Warnings and Precautions (5.4)].
  • In patients with volume depletion, correct this condition before initiating STEGLUJAN [see Warnings and Precautions (5.5), Use in Specific Populations (8.5, 8.6)].

Recommended Dosage

  • The recommended starting dose of STEGLUJAN is 5 mg ertugliflozin/100 mg sitagliptin once daily, taken in the morning, with or without food.
  • For patients treated with ertugliflozin who are being switched to STEGLUJAN, the dose of ertugliflozin can be maintained.
  • For additional glycemic control, the dose may be increased to 15 mg ertugliflozin/100 mg sitagliptin once daily in patients tolerating STEGLUJAN.
  • Use is not recommended in patients with an eGFR less than 45 mL/min/1.73 m2.
  • Use of STEGLUJAN is contraindicated in patients with severe renal impairment (<30 mL/min/1.73 m2), end-stage renal disease (ESRD) or on dialysis [see Contraindications (4)].
Share this Article
Latest News
Related Drugs